Why It Matters
Georgia is moving toward allowing pharmacists to distribute ivermectin, an anti-parasitic medication, over the counter to adults without a prescription. The policy shift raises significant public health concerns, as the drug has become the subject of false medical claims on the internet and has been misused by Georgians seeking treatments for conditions it does not address. Medical professionals worry the change could lead to improper use and potential health complications, while proponents argue it would provide safer access to those determined to use the drug regardless of regulatory barriers.
What Happened
On March 19, 2026, the Georgia House Public and Community Health Committee amended legislation to allow pharmacists to distribute ivermectin over the counter to Georgia residents age 18 and older. The ivermectin provision was added to a bill originally focused on updating Department of Public Health provisions that had already passed the Senate earlier in the legislative session.
The amendment passed largely along party lines despite opposition from medical experts, including Johns Creek Democratic Rep. Michelle Au, a physician. Au expressed frustration that the ivermectin language was inserted into the bill during the final weeks of Georgia’s legislative session, which ends April 2, forcing the committee to reconsider legislation that had previously advanced twice.
Rep. Karen Mathiak, a Griffin Republican, sponsored the original proposal. She stated her objective is to ensure people who choose to use ivermectin do so safely, citing current practices where Georgians purchase equine—or horse—ivermectin from agricultural supply stores like Tractor Supply for personal use rather than animal treatment.
Because the bill was amended in the House, it must pass the Senate again before becoming law, creating an additional procedural hurdle during the compressed final weeks of the Georgia legislative session.
By the Numbers
- The bill requires legislative approval in both chambers of the Georgia legislature before the April 2 session end date
- The measure passed the House committee “mostly along party lines,” indicating significant partisan division
- The ivermectin provision was inserted into an existing bill that had already advanced through the Senate twice previously
- The over-the-counter access would be limited to Georgia residents 18 years and older
Zoom Out
Ivermectin has become a focal point of health policy debate across the United States following the COVID-19 pandemic. The drug, which is FDA-approved for treating specific parasitic infections in humans and is commonly used in large doses for livestock parasite prevention, became the subject of widespread internet misinformation claiming effectiveness against COVID-19, cancer, and other conditions for which scientific evidence does not support its use.
This public health messaging challenge extends beyond Georgia. Medical organizations, including the FDA and CDC, have issued repeated warnings against using ivermectin for unapproved purposes. The drug’s veterinary formulations, available at agricultural suppliers, differ in concentration and purity from pharmaceutical-grade human preparations, creating additional safety risks when used without medical supervision.
The Georgia proposal reflects broader tensions in state legislatures between expanding individual access to medications and protecting public health through prescription requirements and medical oversight. Some states have moved to restrict access to ivermectin for non-approved uses, while others have explored making it available more broadly, framing the issue as one of personal choice and medical freedom.
Ivermectin’s legitimate medical uses remain significant. Physicians prescribe the drug for parasitic infections ranging from serious conditions like river blindness to more common issues such as head lice. The pharmaceutical application differs substantially from agricultural use.
What’s Next
The amended bill must return to the Georgia Senate for reconsideration and approval before it can advance to Governor Brian Kemp’s desk for signature. Given the compressed timeline—with the legislative session scheduled to end April 2—passage is not guaranteed.
If approved by both chambers, the legislation would direct Georgia pharmacists to establish protocols for dispensing ivermectin over the counter to adults. The specific details of those protocols remain unclear, including whether pharmacists would be required to provide counseling about appropriate use or approved medical indications.
Medical organizations and public health officials will likely continue monitoring the bill’s progress. The outcome in Georgia could influence similar legislative efforts in other states considering over-the-counter access to ivermectin or other medications currently requiring prescriptions.